HEART FAILURE: Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

This publication has 19 references indexed in Scilit:

• Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (the OPTIMAAL trial)
  The American Journal of Cardiology, 2001
• Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure: The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators
  International Journal of Cardiology, 2001
• Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
  American Heart Journal, 2000
• The Safety and Tolerability of Candesartan Cilexetil in CHF
  Journal of the Renin-Angiotensin-Aldosterone System, 2000
• Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
  Circulation, 1999
• Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design
  Journal of Cardiac Failure, 1999
• Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
  Circulation, 1999
• Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
  Circulation, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997